liver diseases

Dietary Influences Of Liver Disease Studied

harminka — Wed, 01 Jul 2009 13:55:50 -0500

Diets high in protein and cholesterol are associated with a higher risk of hospitalization or death due to cirrhosis or liver cancer, while diets high in carbohydrates are associated with a lower risk. These findings are in the July issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).

How did glycine significantly decrease liver injury?

harminka — Sat, 01 Nov 2008 03:54:42 -0500

The nonessential amino acid glycine has been shown to be anti-inflammatory in several animal injury models.

Risk factors of idiopathic pulmonary fibrosis in HCV patients

harminka — Thu, 23 Oct 2008 12:13:14 -0500

Hepatitis C virus (HCV) is one of the more common causes of chronic liver disease in world with a variety of extrahepatic complications such as essential mixed cryoglobulinemia, membranoproliferative glomerulonep hritis, autoimmune thyroiditis, sialadenitis, and cardiomyopathy.

Hepatitis C treatment is cost-effective for the US prison population

harminka — Tue, 21 Oct 2008 06:33:46 -0500

Treating all U.S. prisoners who have hepatitis C with the standard therapy of pegylated-interferon and ribavirin would be cost-effective, says a new study in the November issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).

Weighing Hepatitis C virus hold on membranes

harminka — Mon, 20 Oct 2008 11:56:25 -0500

Hepatitis C affects around 150 million people worldwide and is a major cause of chronic liver disease. Current treatment involves the anti-viral drugs interferon and ribavirin, both of which have serious side effects.

Implications for treating liver diseases

harminka — Sat, 02 Aug 2008 05:41:59 -0500

Researchers at the University of Pennsylvania School of Medicine have discovered that a protein called FOXA2 controls genes that maintain the proper level of bile in the liver. FOXA2 may become the focus for new therapies to treat diseases that involve the regulation of bile salts. The study was published online this week in Nature Medicine.

Hepatitis C virus may need enzyme's help to cause liver disease

harminka — Wed, 09 Jul 2008 15:10:50 -0500

A key enzyme may explain how hepatitis C infection causes fatty liver – a buildup of excess fat in the liver, which can lead to life-threatening diseases such as cirrhosis and liver cancer, report University of Pittsburgh Graduate School of Public Health and School of Medicine researchers.

Risk Factors for Infection After Liver Transplantation

harminka — Fri, 06 Jun 2008 10:48:28 -0500

Nearly 9 percent of patients who recently underwent liver transplantation suffered a subsequent surgical site infection (SSI). Risk factors included having had biliary-enteric anastomosis (choledocho-jejunal or hepatic-jejunal reconstruction), previous liver or kidney transplant, and more than four red blood cell units transfused.

Increased potential for liver disease in children

harminka — Tue, 01 Apr 2008 14:10:39 -0500

A history of early-onset paternal obesity increases the odds of elevated liver enzyme levels in offspring and points to the potential for a genetic link between obesity and liver disease, according to a study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

New technique improves outcome for living donor liver transplants

harminka — Thu, 20 Mar 2008 02:52:28 -0500

The University of Alberta Hospital (UAH) is one of only a few centers in Canada that perform living donor liver transplantation, a surgical procedure developed in the late 1980s that expands the organ donor pool. About 80 liver transplants are done a year in Alberta, 10 of those being living-donor.

How to detect low abundant lamivudine-resistant mutants?

harminka — Wed, 16 Jan 2008 09:09:51 -0600

Lamivudine is an effective antiviral agent for treatment of patients with chronic hepatitis B and advanced liver diseases.

Protein protects brain against compound in lead poisoning, liver disease

harminka — Fri, 07 Dec 2007 07:01:34 -0600

Scientists have discovered that a protein known as PEPT2 protects the brains of mice from a naturally occurring but potentially toxic compound present in lead poisoning and in a class of liver diseases that can cause serious neurological complications.